In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, ...

Early and accurate diagnosis of Alzheimer's disease remains crucial, especially with recent breakthroughs in treatments for ...

Mayo Clinic researchers validated an FDA-approved blood test that diagnoses Alzheimer’s disease with 95% sensitivity and 82% ...

Revolutionary blood testing technology now identifies cancer and Alzheimer's disease before symptoms appear. Advanced genetic ...

A new Fujirebio Diagnostics blood test identifies beta-amyloid, a brain plaque that is a key marker for Alzheimer’s disease.

Statins, long hailed for lowering cholesterol, might offer an unexpected benefit beyond heart health—they could help slow ...

In your biological library, known as the brain, there are countless stories stored across billions of shelves. But with age, some sections start to collapse. No ...

The lower costs and convenience of a blood test could also help expand use ... "Today's clearance is an important step for Alzheimer's disease diagnosis, making it easier and potentially more ...

A large-scale study that will pilot the use of blood tests to diagnose Alzheimer’s disease has been announced in the UK, in the hope of finding ways to spot people in the earliest stages of the ...

The FDA has approved the first blood test for Alzheimer's disease based on a blood test – from Fujirebio – in a step forward for early diagnosis. The test, dubbed the Lumipulse G pTau217/ß ...

Ixico said it was contracted by Fujirebio Diagnostics Inc, a Tokyo-based biomarker research company, to assist with the development of a new blood-based test for Alzheimer's disease called Lumipulse.